Archive — US — techcrunch
Epstein-linked longevity guru Peter Attia leaves David Protein, and his ownstartup ‘won’t comment’
Dr. Peter Attia has resigned as Chief Science Officer of David Protein after links to Jeffrey Epstein emerged through a recent document release. Attia expressed shame over crude emails but denies involvement in criminal activities. His resignation may also impact Biograph, a healthcare startup he co-founded, which has distanced itself from him. Attia is known for his work in longevity and preventive health.
Key points
- Peter Attia has stepped down from David Protein due to exposure from Epstein-related documents.
- Attia expressed shame over certain crude emails exchanged with Epstein but denies wrongdoing.
- David Protein has raised significant funding and gained popularity with its high-protein bars.
- Biograph, a healthcare startup co-founded by Attia, is distancing itself from him, omitting his name from public materials.
- Attia is a prominent figure in longevity science, known for his book and podcast discussing health optimization.
Why it matters
- The incident highlights the ongoing scrutiny and implications of connections to Jeffrey Epstein, affecting multiple individuals and businesses.
- Current trends in IT include a shift towards preventive health technologies, making the actions of figures like Attia highly relevant.
- The rise of health-tech startups parallels increased public interest in longevity and well-being, a trend likely to continue into 2025.
Attia's resignation from David Protein reflects the significant repercussions of past associations, particularly seen through the lens of public and investor perception in a rapidly evolving health and technology landscape.